Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilization of glycemia
AssigneeLesaffre Et Compagnie
InventorLucien Lesaffre
Life of this patent
Estimating the term…
Abstract
The invention relates to agents and preparations for the treatment or prevention of hyperglycemia, or for the stabilisation of glycemia, based on the cell walls of yeast and preparation of a corresponding therapeutic composition.
Claims15
A method for treating hyperglycemia in a subject with type 2 diabetes, comprising administering to said subject an agent consisting of cell walls of yeast of the species Saccharomyces cerevisiae, said yeast cell walls having:
- a total content of both glucans and mannans of at least 34.0% by mass on a dry matter basis, and
- a glycogen content of less than 10.0% by mass on a dry matter basis.
A method for inhibiting hyperglycemia in a subject with type 2 diabetes, comprising administering to said subject an agent consisting of cell walls of yeast of the species Saccharomyces cerevisiae, said yeast cell walls having:
- a total content of both glucans and mannans of at least 34.0% by mass on a dry matter basis, and
- a glycogen content of less than 10.0% by mass on a dry matter basis.
A method for stabilizing glycemia in a subject with type 2 diabetes, comprising administering to said subject an agent consisting of cell walls of yeast of the species Saccharornyces cerevisiae, said yeast cell walls having:
- a total content of both glucans and mannans of at least 34.0% by mass on a dry matter basis, and
- a glycogen content of less than 10.0% by mass on a dry matter basis.
Dependencies are inferred from the claim text.